Related Experiment Video
Updated: Jan 1, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
24.4K
Botulin Toxin Use in Rosacea and Facial Flushing Treatment
Jacopo Scala1, Aleksandra Vojvodic2, Petar Vojvodic3
1University G. Marconi, Rome, Italy.
Open Access Macedonian Journal of Medical Sciences
|December 19, 2019
Summary
Botulinum toxin (BTX) effectively treats rosacea and facial flushing by impacting nerve signals. This neurotoxin offers promising dermatological applications beyond its established uses.
Area of Science:
- Dermatology
- Neuroscience
- Pharmacology
Background:
- Botulinum toxin (BTX), a neurotoxin from Clostridium botulinum, inhibits acetylcholine release.
- BTX is widely used for neuromuscular conditions and cosmetic purposes.
- Emerging research explores BTX for dermatological conditions like rosacea and facial flushing.
Purpose of the Study:
- To analyze published data on the off-label application of Botulinum toxin for rosacea and facial flushing.
- To understand the proposed mechanisms behind BTX efficacy in treating these dermatological conditions.
Main Methods:
- Literature review of studies on Botulinum toxin for rosacea and flushing.
- Analysis of data retrieved from PubMed.
Main Results:
- Botulinum toxin has shown positive results in treating rosacea and facial flushing.
- The exact mechanism is not fully understood but involves inhibiting acetylcholine release from autonomic nerves.
- BTX may also block substance P and CGRP, modulating cutaneous vasodilation.
Conclusions:
- Botulinum toxin demonstrates potential as an effective treatment for rosacea and facial flushing.
- Further research is warranted to fully elucidate the mechanisms of action.
- BTX represents a promising therapeutic option for specific dermatological vascular conditions.
More Related Videos
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.0K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.0K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
826
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
826
01:26Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.3K
01:28Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K